KING OF PRUSSIA, Pa., Feb. 24, 2026 (GLOBE NEWSWIRE) -- Paratek Pharmaceuticals, Inc., a privately held pharmaceutical company focused on the development and commercialization of specialty therapies ...
A: Anthrax is a hardy bacterium that can form a protective capsule, called a spore. The spore can survive long periods in the environment, infecting animals and people through the skin, stomach or ...
BOSTON, Dec. 19, 2022 (GLOBE NEWSWIRE) -- Paratek Pharmaceuticals, Inc. (PRTK) today announced positive top line data from a pilot rabbit efficacy study evaluating NUZYRA’s effectiveness in the ...
NEW YORK (MedscapeWire) Jan 03 — A nuclear medicine procedure that has the potential to safely pinpoint even the smallest amounts of infected tissue has received preliminary approval for a clinical ...
In the event of an attack with biological weapons, would the anthrax vaccine offer protection against pulmonary anthrax, or would rapid administration of antibiotics be more efficacious? —LAWRENCE ...
Health officials say they don’t know where Bob Stevens contracted the disease, but they believe it is an isolated case. Stevens was a photo editor at the tabloid paper The Sun. He was the first person ...
BOSTON, Sept. 27, 2021 (GLOBE NEWSWIRE) -- Paratek Pharmaceuticals, Inc. (Nasdaq: PRTK) today announced that the Biomedical Advanced Research and Development Authority (BARDA), part of the Office of ...
The MarketWatch News Department was not involved in the creation of this content. -- First of two Pivotal Efficacy Studies support future sNDA submission for Treatment of Pulmonary Anthrax -- Oral ...
In the event of a biological weapons attack, would the anthrax vaccine offer protection against pulmonary anthrax, or would rapid administration of antibiotics be more efficacious? —LAWRENCE SHEDWICK, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results